ReviewMolecular aspects of medicine2026
Extracellular vesicles and their cargo molecules for peripheral nerve injuries and neuropathies: The composition, properties, and impact.
Review in Molecular aspects of medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Peripheral nerve repair remains a major clinical challenge due to limited functional recovery and the lack of effective therapeutic options. Extracellular vesicles (EVs) have emerged as potential mediators of nerve regeneration due to their roles in cell-to-cell communication and the delivery of diverse bioactive molecules. The regenerative potential of EVs largely depends on the type of cell they originate from, which determines their molecular cargo and therapeutic potential. This review provides a comprehensive and focused analysis on the source-specific composition of EVs, and how different EVs distinctly influence neuroprotective, immunomodulatory, and neuroregenerative properties with direct relevance to peripheral nerve injury (PNI). We also highlight current evidence on how EVs modulate nerve repair pathways and discuss the implications of their source-specific content in optimizing EV-based therapies alongside recent technological advances for PNI. By highlighting key differences in regenerative-associated signaling, this review provides insight into optimizing EV-based therapies for PNI and outlines prospects for clinical application.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.